Back to EZorb Newsletter Index





In this issue:


1. Share Success: Letters From Readers
2. Research News: COPD and Osteoporosis Possibly Connected
3. Useful Links
4. Calcium Absorption Test
5. What Are Others Saying About EZorb and Marvlix?

1. Share Success: Letters From Readers 


Letter I: From Barbara H.

Received at Testimonial Submit Form on Monday, October 21, 2013 at 12:00:04



I am so thankful that a friend of mine introduced me to EZorb. I've been using it faithfully for some time and just had a Bone Density Test.

My doctor was thrilled with the results. I am 68 years old and my last test was five years ago. The recent test showed a 22% increase in my bone density!!! I attribute it to your product.

Thank you so much. I'm telling all my friends about it as well.

Letter II: From Marlene

Received at Testimonial Submit Form on Tuesday, July 30, 2013 at 11:16:20



Hi, my name is Marlene. I have been taking ezorb for a few years now.

I have found that using the maximum amount is beneficial for me. I have severe osteoarthritis mostly in the upper back and both knees.

For the most part, ezorb has helped immensely. Most days I am not aware that I have the arthritis. It is hard to explain to others how a calcium product helps, but I know that it does. I used to suffer from bone spurs, but have not had to deal with this since beginning ezorb.

I know that this product is more expensive than what I can purchase at a retail store, but it is worth the price even on a limited budget.

Letter III: From Douglas


Received at Testimonial Submit Form on Tuesday, May 14, 2013 at 11:51:32



Hi, my name is Douglas. I am a 57 y.o. R.N. and body builder.

Imagine that! After lifting weights fairly intensively 3 days a week for 5 years I developed, over time, severe pain in my right shoulder, presumably a lifting injury, that not only limited my range of motion but woke me up at night.

I finally consulted an orthopedic surgeon who ordered an MRI, which showed a bone spur and was subsequently scheduled for surgery.

I may be an RN, but I don't like the idea of someone making incisions on my body and have always much preferred nutritional approaches to allowing the body to heal itself.

After doing a google search for supplements that would help with bone spur pain, I was delighted to find EZorb listed and went to the website and read all the glowing testimonials. People reported results in as little as 3-5 days! With a 30 day money back guaranty I had nothing to lose to try the product and cancelled the surgery.

After taking massive amounts of EZorb for 30 days, and having no results, I rescheduled the surgery and almost returned the remaining product to get my money back, but after calling and talking to 1 of the scientists , I decided to follow his advice and give it 1 more month.

Cancelled the surgery again and resumed taking 10 pills a day. In 15 days the pain was gone and I had full range of motion of my right shoulder!!!

I cannot adequately articulate how grateful I am for the advice I received and for the product that has resolved the incessant, unrelenting pain and allowed me to resume lifting! My thanks to you all and God bless you!


From the Desk of EZorb Newsletter Editor:

This newsletter is now read by over 70,000 subscribers worldwide. Success stories you have contributed over the years have had a great impact on many people's quality of life. Your continuous support will be greatly appreciated by tens of thousands who have been suffering and would continuously suffer, without your help! Please email your story to sharesuccess @ or simply post it at Testimonial Submit Form. Your personal information will never be revealed to the public.

2. Research News: COPD and Osteoporosis Possibly Connected


Researchers have shown that bone resorption is increased during exacerbations of chronic obstructive pulmonary disease (COPD), adding to growing evidence of a strong association between the disease and osteoporosis.

Furthermore, they demonstrate that this change in bone mineral dynamics was predominantly influenced by the inflammation, hypoxia, and increased oxidative stress brought about by acute respiratory exacerbation.

The study of 85 hospitalized COPD patients showed that during exacerbation mean levels of the bone resorption marker collagen type 1 B-isomerized C-terminal telopeptide (beta CL) were significantly greater than during stable disease (approximately 30 days following admission) at 0.521 ng/mL compared with 0.408 ng/mL. But both of these levels were significantly higher than that observed among a group of 47 controls, at a mean of 0.362 ng/mL.

The change in bone resorption rate observed in acute COPD exacerbations was accompanied by expected declines in respiratory function and the development of significant hypoxia. And while inflammation was persistent in the stable state, it was intensified during exacerbations, as evidenced by increased neutrophil counts and high-sensitivity C-reactive protein levels.

Additionally, total oxidative status was higher in COPD patients than controls, a difference that became highly significant during exacerbations (15.9 vs 10.1 mmol/L).

Using multiple linear regression analysis, the authors found that inflammation explained around 18% of variability in beta CL values, while hypoxia and inflammation together explained around 25%. However, it was the combination of inflammation, hypoxia, and oxidative status that could best account for the changes in beta CL, being responsible for 60% of variability, "which firmly established a connection between inflammation, respiratory dysfunction and oxidative stress status," say study author Ivana Stanojkovic (University of Belgrade, Serbia) and colleagues.

The team also notes that levels of matrix metalloproteinase (MMP)-9 and tissue inhibitor of metalloproteinase (TIMP)-1 were significantly higher among COPD patients, during both exacerbation and in the stable state. And a slight increase in the former and decrease in the latter during exacerbation resulted in a significantly raised MMP-9 to TIMP-1 ratio, supporting the theory of unbalanced protease activity in COPD, leading to preferential loss of protein rich tissues such as skeletal muscle and bone connective tissue.

"Results of this analysis have confirmed the strong relationship between proteolytic and bone resorption processes in patients with jeopardized respiratory function," the researchers conclude in Clinical Biochemistry.

Original research was published in Clin Biochem2013; Advance online publication.

3. Useful Links

Frequently Asked Questions & Answers

EZorb Clinical Studies

Marvlix Benefits

Order Now



4. Calcium Absorption Test

EZorb Calcium has set a new world record of absorption rate. You can compare EZorb with other calcium supplements by using the simple step-by-step instructions we provide. E-mail your request to test @ for a copy of the instructions.



5. What Are Others Saying About EZorb and Marvlix?

EZorb and Marvlix have restored confidence in thousands of men and women. It has brought happiness and healthy life to families around the world. Click here to read what people say about EZorb and Marvlix.

Back to EZorb Newsletter Index

  Copyright 2013 Elixir Industry